, Singapore
220 views

IHH Healthcare grants approval for Agilus IPO plans

The timing of the IPO will be determined by Agilus and Fortis.

SGX-listed IHH’s board of directors declared that Board of Directors of Fortis and the Board of Directors of Agilus to regulation 30 of Securities and exchange board of India.

In a statement, IHH said the companies had their own meetings held on 4 August 2023, where they “considered and granted their confirmation / approval for Agilus to initiate an IPO process by way of an offer of sale of such number of equity shares as may be offered by certain existing and eligible shareholders of Agilus in the IPO to comply with applicable laws.” 

“The actual timing and implementation of the IPO will be subject to the determination of Fortis’ and Agilus’ respective boards, after considering the prevailing market conditions and other relevant factors at such price determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018,” read the statement.

“The IPO shall also be subject to the approval of the members of Fortis, and other regulatory approvals, as required under applicable law,” it added.

Join Singapore Business Review community

Follow the link for more news on

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.